| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |